Nalion (Alprazolam)

Alprazolam is employed in the treatment of several anxiety‑related conditions, where it modulates GABA‑mediated inhibition to calm overactive neural circuits, thereby reducing excessive worry, fear, and physical symptoms of anxiety, and can be used as needed under medical supervision.

• Generalized anxiety disorder: reduces persistent worry and tension, improving daily functioning.
• Panic disorder: lessens the frequency and intensity of panic attacks.
• Anxiety associated with depression: alleviates co‑existing anxiety symptoms, supporting overall mood stabilization.
• Situational anxiety: provides short‑term symptom control during stressful events.

• Alprazolam acts as a positive allosteric modulator at the benzodiazepine binding site of the GABA‑A receptor complex. By increasing the frequency of chloride channel opening in response to GABA, it enhances inhibitory neurotransmission, leading to neuronal hyperpolarization and a reduction in CNS excitability, which produces anxiolytic, sedative, and muscle‑relaxant effects. The effect is rapid, reaching peak plasma concentrations within one to two hours after oral administration, and the enhanced GABAergic tone persists for several hours, accounting for its clinical efficacy in acute anxiety management.

Alprazolam may cause a range of adverse reactions, varying from mild to severe, which should be monitored during therapy.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Impaired coordination: reduced motor control and balance.
• Memory problems: difficulty recalling recent events.
• Mood changes: irritability or mild depression.
• Gastrointestinal upset: nausea, constipation or abdominal discomfort.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing, particularly with high doses or CNS depressants.
• Severe allergic reaction: rash, itching, swelling, or anaphylaxis.
• Withdrawal seizures: risk of seizures if the drug is stopped abruptly after prolonged use.
• Depression or suicidal thoughts: emergence or worsening of depressive symptoms.
• Hallucinations or psychosis: rare episodes of altered perception.
• Liver dysfunction: abnormal liver enzyme levels indicating hepatic injury.

When prescribing alprazolam, clinicians should consider several safety precautions to minimize risks and ensure appropriate use.

• Assess dependence risk: evaluate patient history for substance abuse before initiating therapy.
• Limit duration: use the lowest effective dose for the shortest period required.
• Avoid abrupt discontinuation: taper the dose gradually to prevent withdrawal symptoms.
• Caution in respiratory disorders: monitor closely in patients with COPD or sleep apnea.
• Concomitant CNS depressants: avoid or adjust dosage when combined with opioids, alcohol, or antihistamines.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Alprazolam interacts with several medications, affecting its metabolism or enhancing central nervous system depression.

Major Interactions (Avoid)

• Opioids: combined use can cause profound respiratory depression and sedation.
• Barbiturates: additive CNS depressant effects may lead to coma.
• Antifungal azoles (ketoconazole, itraconazole): increase alprazolam plasma levels, raising toxicity risk.
• Macrolide antibiotics (erythromycin, clarithromycin): inhibit metabolism, leading to elevated drug concentrations.
• Alcohol: synergistic sedation and impairment of psychomotor performance.

Moderate Interactions (Monitor Closely)

• Antidepressants (SSRIs, SNRIs): may enhance serotonergic effects and increase sedation.
• Antihistamines (diphenhydramine): additive drowsiness.
• Anticonvulsants (phenytoin, carbamazepine): may reduce alprazolam levels, decreasing efficacy.
• Cimetidine: can modestly raise alprazolam concentrations.
• Grapefruit juice: may inhibit CYP3A4, leading to higher plasma levels.